Cite
HARVARD Citation
Gasperini, C. et al. (n.d.). Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies. Expert opinion on investigational drugs. pp. 1243-1253. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Gasperini, C. et al. (n.d.). Drugs in clinical development for multiple sclerosis: focusing on anti-CD20 antibodies. Expert opinion on investigational drugs. pp. 1243-1253. [Online].